These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10941348)

  • 21. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
    Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
    Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interpectoral nodes as the initial site of recurrence in breast cancer.
    Komenaka IK; Bauer VP; Schnabel FR; Joseph KA; Horowitz E; Ditkoff BA; El-Tamer MB
    Arch Surg; 2004 Feb; 139(2):175-8. PubMed ID: 14769576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benign proliferative lesions and in situ carcinoma of the breast: new immunohistological findings and their biological implications.
    Böcker W; Bier B; Ludwig A; de Hesselle B; Gerdes J
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():41-9. PubMed ID: 7507748
    [No Abstract]   [Full Text] [Related]  

  • 24. Fine-needle aspiration biopsy of invasive micropapillary carcinoma of the breast: a report of five cases.
    Bayramoglu H; Zekioglu O; Erhan Y; Ciriş M; Ozdemir N
    Diagn Cytopathol; 2002 Oct; 27(4):214-7. PubMed ID: 12357498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel lymph node biopsy for breast cancer.
    Swanson JO
    J Insur Med; 2001; 33(2):195-7. PubMed ID: 11510518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scoring systems for the prediction of non-sentinel node metastasis in breast cancer patients.
    Barranger E; Morel O; Coutant C
    Am J Surg; 2008 Nov; 196(5):799-800. PubMed ID: 18353276
    [No Abstract]   [Full Text] [Related]  

  • 27. Paracortical axillary sentinel lymph node ectopic breast tissue.
    Zynger DL; McCallum JC; Everton MJ; Yeldandi AV; Susnik B
    Pathol Res Pract; 2009; 205(6):427-32. PubMed ID: 19168294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneic expression of estrogen receptor between the primary tumor and the corresponding involved lymph nodes in patients with node-positive breast cancer and its implications in patient outcome.
    Iguchi C; Nio Y; Itakura M
    J Surg Oncol; 2003 Jun; 83(2):85-93. PubMed ID: 12772201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Breast-conserving surgery in breast cancer].
    Ruggiero R; Procaccini E; Freda F; Iovino F; Irlandese E; Gili S; Lo Schiavo F
    G Chir; 2005; 26(11-12):449-52. PubMed ID: 16472427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast.
    Ansari B; Ogston SA; Purdie CA; Adamson DJ; Brown DC; Thompson AM
    Br J Surg; 2008 May; 95(5):547-54. PubMed ID: 18386775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glandular structures in an intraoperative axillary sentinel lymph node biopsy: a diagnostic dilemma.
    Nga ME; Putti TC
    Histopathology; 2006 Mar; 48(4):475-7. PubMed ID: 16487377
    [No Abstract]   [Full Text] [Related]  

  • 32. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.
    Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma.
    Sakr R; Antoine M; Barranger E; Dubernard G; Salem C; Daraï E; Uzan S
    Breast J; 2008; 14(1):55-60. PubMed ID: 18186866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The reliability and accuracy of intraoperative imprint cytology of sentinel lymph nodes in breast cancer.
    Pogacnik A; Klopcic U; Grazio-Frković S; Zgajnar J; Hocevar M; Vidergar-Kralj B
    Cytopathology; 2005 Apr; 16(2):71-6. PubMed ID: 15787648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
    J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma.
    Krishnamurthy S; Sneige N; Bedi DG; Edieken BS; Fornage BD; Kuerer HM; Singletary SE; Hunt KK
    Cancer; 2002 Sep; 95(5):982-8. PubMed ID: 12209680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathologic assessment of the sentinel lymph node in breast cancer.
    Turner RR
    Ann Surg Oncol; 2001 Oct; 8(9 Suppl):56S-59S. PubMed ID: 11599901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry. Part II. Results.
    Salem AA; Douglas-Jones AG; Sweetland HM; Mansel RE
    Eur J Surg Oncol; 2006 Jun; 32(5):484-7. PubMed ID: 16569493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does stereotactic core needle biopsy increase the risk of local recurrence of invasive breast cancer?
    Kwo S; Grotting JC
    Breast J; 2006; 12(3):191-3. PubMed ID: 16684313
    [No Abstract]   [Full Text] [Related]  

  • 40. [Micrometastases of the axillary lymph nodes in breast cancer. An immunohistochemical study].
    Ronay G; Tomesch A; Tulusan AH
    Pathologe; 1989 Sep; 10(5):289-93. PubMed ID: 2477837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.